EL.En

Accelerating Laser Adoption Will Spur Expansion Despite Tariff Risks

AnalystHighTarget

Not Invested

Community Contributor

Published

17 Jul 25

AnalystHighTarget's Fair Value

€14.70

25.8% undervalued

10 Sep

€10.91

0.6%

-6.0%

0.6%

-6.0%

You can edit this narrative until Jul 17 9:28 PM. Then, changes will post as Updates.

Author's Valuation

€14.7

25.8% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

€14.7

25.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.90%

Medical Equipment revenue growth rate

0.39%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

9.95%

Calculation

€72.09m

Earnings '28

21.71x

PE Ratio '28

€1.56b

Market Cap '28

€1.56b

Market Cap '28

77.19m

No. shares '28

€20.27

Share Price '28

€20.27 Share Price '28

Discounted to 2025 @ 9.99% p.a.

€15.24

Fair Value '25